Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension.

MLA

Grech, Olivia, et al. “Effect of Glucagon like Peptide-1 Receptor Agonist Exenatide, Used as an Intracranial Pressure Lowering Agent, on Cognition in Idiopathic Intracranial Hypertension.” Eye (London, England), vol. 38, no. 7, May 2024, pp. 1374–79. EBSCOhost, https://doi.org/10.1038/s41433-023-02908-y.

APA

Grech, O., Mitchell, J. L., Lyons, H. S., Yiangou, A., Thaller, M., Tsermoulas, G., Brock, K., Mollan, S. P., & Sinclair, A. J. (2024). Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension. Eye (London, England), 38(7), 1374–1379. https://doi.org/10.1038/s41433-023-02908-y

Chicago

Grech, Olivia, James L Mitchell, Hannah S Lyons, Andreas Yiangou, Mark Thaller, Georgios Tsermoulas, Kristian Brock, Susan P Mollan, and Alexandra J Sinclair. 2024. “Effect of Glucagon like Peptide-1 Receptor Agonist Exenatide, Used as an Intracranial Pressure Lowering Agent, on Cognition in Idiopathic Intracranial Hypertension.” Eye (London, England) 38 (7): 1374–79. doi:10.1038/s41433-023-02908-y.